Trial intelligence / Profile preview

Adductor channel block for pain control after anterior cruciate ligament surgery

NL-OMON51570Recruiting

Sponsor
St. Antonius Ziekenhuis
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in anterior cruciate ligament injury comparing Adductor channel block with levobupivacaine with Adductor channel placebo block with sodium chloride (2 arms). Primary endpoint: Postoperative pain within 24 hours. Started Aug 2022; status: recruiting.

02

Drugs

levobupivacainesodium chloride
03

Conditions

anterior cruciate ligament injury

Beyond the preview

Go deeper on NL-OMON51570.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON51570.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call